MYND Life Sciences Announces $3 Million Convertible Debenture Unit Offering

MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital...

Silo Pharma Advances Psychedelic Patent Portfolio

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to...

Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon...

Microdosing LSD Makes Me a Better Mom

Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling...

Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the...

Same But Different: Antidepressant Mechanisms of Psilocybin and Ketamine

Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent...

Load more